Journal article
203 Pb-VMT-ð-NET Scintigraphy of a Patient With Neuroendocrine Tumor
Clinical nuclear medicine, Vol.48(1), p.54
01/01/2023
DOI: 10.1097/RLU.0000000000004464
PMCID: PMC9762701
PMID: 36257061
Abstract
In an end-stage midgut neuroendocrine tumor patient with carcinoid heart disease, right ventricular dysfunction, mildly reduced renal function, and refractory to 6 cycles of 177 Lu-HA-DOTATATE therapy, planar, and 22 hours SPECT/CT images were acquired after injection of 224 MBq of 203 Pb-VMT-ð-NET to assess the feasibility of performing 212 Pb-VMT-ð-NET therapy. A comparison of the 1.5 and 22 hours SPECT/CT images with 68 Ga-HA-DOTATATE PET/CT showed high uptake of 203 Pb-VMT-ð-NET in liver metastases matching with the results of the PET/CT investigation.
Details
- Title: Subtitle
- 203 Pb-VMT-ð-NET Scintigraphy of a Patient With Neuroendocrine Tumor
- Creators
- Dirk MÈllerHendrik HerrmannMichael K SchultzChristoph SolbachThomas EttrichVikas Prasad
- Resource Type
- Journal article
- Publication Details
- Clinical nuclear medicine, Vol.48(1), p.54
- DOI
- 10.1097/RLU.0000000000004464
- PMID
- 36257061
- PMCID
- PMC9762701
- NLM abbreviation
- Clin Nucl Med
- ISSN
- 0363-9762
- eISSN
- 1536-0229
- Publisher
- Lippincott Williams & Wilkins, WK Health
- Language
- English
- Date published
- 01/01/2023
- Description audience
- Academic
- Academic Unit
- Radiology; Stead Family Department of Pediatrics; Radiation Oncology
- Record Identifier
- 9984334947602771
Metrics
22 Record Views